查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1721427

兽医骨移植和替代品市场机会、成长动力、产业趋势分析及 2025 - 2034 年预测

Veterinary Bone Grafts and Substitutes Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034
出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2024 年全球兽医骨移植和替代品市场价值为 2.451 亿美元，预计到 2034 年将以 6.4% 的复合年增长率增长至 4.486 亿美元。业内专家表示，随着全球宠物拥有量的增加以及对先进兽医骨科治疗的需求持续增长，市场正在稳步发展。伴侣动物和农场动物意外伤害、关节疾病和与年龄相关的骨骼问题的增加极大地导致了骨科干预的激增。专业人士指出，再生兽医学的广泛转变为动物伤害的治疗方式带来了显着的转变。

兽医骨移植和替代品市场 - IMG1

兽医越来越多地利用创新的移植技术，包括同种异体移植、异种移植和合成替代品，以确保更快的癒合和改善术后效果。人们对磷酸钙和羟基磷灰石陶瓷等生物相容性材料的偏好迅速增长，兽医认为它们能够模仿天然骨骼结构、促进有机再生，同时减少术后併发症。分析师也强调，随着对先进兽医护理认识的不断扩大，宠物主人和临床医生都倾向于提供更好的预后和恢復时间表的解决方案，从而推动了对下一代骨移植技术的需求。

市场范围
起始年份 2024
预测年份 2025-2034
起始值 2.451亿美元
预测值 4.486亿美元
复合年增长率 6.4%

根据产品类型，专家确认自体移植领域在 2024 年创造了 9,980 万美元的收入。兽医将这种方法（移植物来自同一动物）描述为黄金标准，因为它具有卓越的整合能力。他们解释说，自体移植透过支持成骨、骨诱导和骨传导提供三重治疗效果。由于这些特性，专业人士普遍倾向于在动物的牙科和骨科手术中使用自体移植，特别是在长期稳定性和生物相容性至关重要的情况下。

根据动物类型，分析师报告称，到 2024 年，狗将占据 56.6% 的主导市场。他们将这一优势归因于犬类陪伴日益增长的文化趋势以及宠物医疗保健支出的持续增长。兽医观察到，骨骼损伤、骨折和退化性关节疾病在狗中特别常见，这导致移植手术的频率更高。产业专家强调，越来越多的狗主人选择复杂的外科手术治疗，进一步推动了骨移植和骨替代品的采用。

2023年，美国兽医骨移植和替代品市场规模达9,480万美元。专业人士认为，这一增长得益于美国先进的兽医医疗基础设施和较高的宠物拥有率。手术中骨移植的常规使用以及完善的移植材料分销网络的存在，帮助美国成为全球范围内的主要收入来源。

全球兽医骨移植和替代品市场的主要参与者包括 Lynch Biologics、Veteregen、Nutramax Laboratories Veterinary Sciences、TheraVet、BioChange、Movora (Vimian Group AB)、S-VETOSS、Rita Leibinger、Biomimetic Solutions、Wishbone、Biomendex。产业分析师观察到，领先的公司正在透过建立策略性分销联盟、扩大产品供应以及大力投资再生兽医研究来增强其市场占有率。许多引进的先进骨移植材料可改善癒合动力和生物相容性。一些参与者专注于利基兽医应用，而其他参与者则扩大其地理覆盖范围以进入新兴市场。

目录

第一章：方法论与范围

第二章：执行摘要

第三章：行业洞察

  • 产业生态系统分析
  • 产业衝击力
    • 成长动力
      • 宠物拥有量和支出增加
      • 动物骨科疾病盛行率不断上升
      • 兽医再生医学的进展
      • 宠物保险覆盖范围不断扩大
    • 产业陷阱与挑战
      • 骨移植和骨替代品成本高昂
  • 成长潜力分析
  • 监管格局
  • 未来市场趋势
  • 波特的分析
  • PESTEL分析

第四章：竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 竞争定位矩阵
  • 策略仪表板

第五章：市场估计与预测：依产品类型，2021 - 2034 年

  • 主要趋势
  • 自体移植
  • 同种异体移植
  • 异种移植
  • 其他产品类型

第六章：市场估计与预测：按动物，2021 - 2034 年

  • 主要趋势
  • 狗
  • 猫
  • 马匹
  • 其他动物

第七章：市场估计与预测：依形式，2021 - 2034

  • 主要趋势
  • 粉末
  • 油灰
  • 颗粒
  • 注射剂
  • 其他形式

第八章：市场估计与预测：按应用，2021 - 2034 年

  • 主要趋势
  • 骨科
  • 牙科
  • 其他应用

第九章：市场估计与预测：依最终用途，2021 - 2034 年

  • 主要趋势
  • 兽医院
  • 兽医诊所
  • 其他最终用途

第十章：市场估计与预测：按地区，2021 - 2034 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：公司简介

  • Biomendex
  • BioChange
  • Biomimetic Solutions
  • Cavix
  • Exabone
  • Lynch Biologics
  • Movora (Vimian Group AB)
  • Nutramax Laboratories Veterinary Sciences
  • Rita Leibinger
  • S-VETOSS
  • TheraVet
  • Veteregen
  • Wishbone
简介目录
Product Code: 13469

The Global Veterinary Bone Grafts and Substitutes Market was valued at USD 245.1 million in 2024 and is estimated to grow at a CAGR of 6.4% to reach USD 448.6 million by 2034. Industry experts stated that the market is witnessing steady traction as pet ownership rises globally and the demand for advanced veterinary orthopedic treatments continues to grow. The rise in accidental injuries, joint disorders, and age-related skeletal issues among companion and farm animals has significantly contributed to the surge in orthopedic interventions. Professionals noted that the widespread shift toward regenerative veterinary medicine has brought a notable transformation to how animal injuries are treated.

Veterinary Bone Grafts and Substitutes Market - IMG1

Veterinary practitioners are increasingly leveraging innovative grafting techniques, including allografts, xenografts, and synthetic substitutes, to ensure faster healing and improved post-operative outcomes. The preference for biocompatible materials such as calcium phosphate and hydroxyapatite ceramics has grown rapidly, with veterinarians citing their ability to mimic natural bone structure and promote organic regeneration while reducing post-surgical complications. Analysts also highlighted that as awareness of advanced veterinary care expands, both pet owners and clinicians are leaning toward solutions that offer better prognosis and recovery timelines, fueling the demand for next-gen bone graft technologies.

Market Scope
Start Year2024
Forecast Year2025-2034
Start Value$245.1 Million
Forecast Value$448.6 Million
CAGR6.4%

Based on product types, experts confirmed that the autografts segment generated USD 99.8 million in 2024. Veterinary surgeons described this method-where the graft is sourced from the same animal-as the gold standard due to its superior integration capabilities. They explained that autografts offer a triple therapeutic effect by supporting osteogenesis, osteoinduction, and osteoconduction. Because of these attributes, professionals widely prefer autografts for both dental and orthopedic procedures in animals, particularly where long-term stability and biological compatibility are paramount.

By animal type, analysts reported that dogs accounted for a dominant 56.6% market share in 2024. They linked this stronghold to the growing cultural trend of canine companionship and the consistent rise in pet healthcare spending. Veterinarians observed that bone injuries, fractures, and degenerative joint diseases are particularly prevalent in dogs, which has led to a higher frequency of grafting procedures. Industry specialists emphasized that dog owners are increasingly opting for sophisticated surgical treatments, further boosting the adoption of bone grafts and substitutes.

The United States Veterinary Bone Grafts and Substitutes Market reached USD 94.8 million in 2023. According to professionals, this growth is underpinned by the country's advanced veterinary healthcare infrastructure and high rates of pet ownership. Routine use of bone grafting in surgeries and the presence of a well-established distribution network for graft materials have helped maintain the US as a key revenue generator within the global landscape.

Key players in the Global Veterinary Bone Grafts and Substitutes Market include Lynch Biologics, Veteregen, Nutramax Laboratories Veterinary Sciences, TheraVet, BioChange, Movora (Vimian Group AB), S-VETOSS, Rita Leibinger, Biomimetic Solutions, Wishbone, Biomendex, Exabone, and Cavix. Industry analysts observed that leading companies are enhancing their market presence by forging strategic distribution alliances, broadening their product offerings, and investing heavily in regenerative veterinary research. Many introduced advanced bone graft materials that offer improved healing dynamics and biocompatibility. While some players focused on niche veterinary applications, others expanded their geographical footprint to tap into emerging markets.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 3600 synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing pet ownership and expenditure
      • 3.2.1.2 Growing prevalence of orthopedic conditions in animals
      • 3.2.1.3 Advancements in veterinary regenerative medicine
      • 3.2.1.4 Growing pet insurance coverage
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of bone grafts and substitutes
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Future market trends
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

  • 5.1 Key trends
  • 5.2 Autografts
  • 5.3 Allografts
  • 5.4 Xenografts
  • 5.5 Other product types

Chapter 6 Market Estimates and Forecast, By Animal, 2021 - 2034 ($ Mn)

  • 6.1 Key trends
  • 6.2 Dogs
  • 6.3 Cats
  • 6.4 Horses
  • 6.5 Other animals

Chapter 7 Market Estimates and Forecast, By Form, 2021 - 2034 ($ Mn)

  • 7.1 Key trends
  • 7.2 Powders
  • 7.3 Putty
  • 7.4 Granules
  • 7.5 Injectables
  • 7.6 Other forms

Chapter 8 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

  • 8.1 Key trends
  • 8.2 Orthopedic
  • 8.3 Dental
  • 8.4 Other applications

Chapter 9 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

  • 9.1 Key trends
  • 9.2 Veterinary hospitals
  • 9.3 Veterinary clinics
  • 9.4 Other end use

Chapter 10 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

  • 10.1 Key trends
  • 10.2 North America
    • 10.2.1 U.S.
    • 10.2.2 Canada
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 France
    • 10.3.4 Spain
    • 10.3.5 Italy
    • 10.3.6 Netherlands
  • 10.4 Asia Pacific
    • 10.4.1 China
    • 10.4.2 Japan
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 South Korea
  • 10.5 Latin America
    • 10.5.1 Brazil
    • 10.5.2 Mexico
    • 10.5.3 Argentina
  • 10.6 Middle East and Africa
    • 10.6.1 South Africa
    • 10.6.2 Saudi Arabia
    • 10.6.3 UAE

Chapter 11 Company Profiles

  • 11.1 Biomendex
  • 11.2 BioChange
  • 11.3 Biomimetic Solutions
  • 11.4 Cavix
  • 11.5 Exabone
  • 11.6 Lynch Biologics
  • 11.7 Movora (Vimian Group AB)
  • 11.8 Nutramax Laboratories Veterinary Sciences
  • 11.9 Rita Leibinger
  • 11.10 S-VETOSS
  • 11.11 TheraVet
  • 11.12 Veteregen
  • 11.13 Wishbone